北陆药业：股东重庆三峡油漆股份有限公司计划减持公司股份不超过1000万股

Group 1 - The core point of the news is that Chongqing Three Gorges Paint Co., Ltd., a shareholder of Beilu Pharmaceutical, plans to reduce its holdings by up to 10 million shares, which represents 1.78% of the company's total share capital [1] - Beilu Pharmaceutical's revenue composition for the year 2024 is primarily from drug production, accounting for 98.88%, while other business income constitutes 1.12% [1] - As of the latest report, Beilu Pharmaceutical has a market capitalization of 4.8 billion yuan [2]